Retrovirus Epidemiology Donor Study-II (REDS II) Molecular Surveillance (MS)

Note that you will be prompted to log in or register an account

Accession Number
HLB00961212a

Study Type
Epidemiology Study

Collection Type
Open BioLINCC Study See bottom of this webpage for request information

Study Period
2006 - 2009

NHLBI Division
DBDR

Dataset(s) Last Updated
January 3, 2018

Clinical Trial URLs
https://clinicaltrials.gov/ct2/show/NCT00097006

Primary Publication URLs
https://www.ncbi.nlm.nih.gov/pubmed/22293432

Consent

Commercial Use Data Restrictions No

Data Restrictions Based On Area Of Research No

Objectives

The objective of the study was to conduct a genetic analysis of incident and prevalent strains of HIV, HCV and HBV by testing blood specimens from HIV, HCV or HBV positive blood donors who gave blood at REDS-II centers, as well as at UBS, NYBC and ARC blood centers between 2006 and 2009.

Background

Genetic variations of human immunodeficiency virus (HIV), hepatitis C virus (HCV), and hepatitis B virus (HBV) can affect diagnostic assays and therapeutic interventions. Recent changes in prevalence of subtypes/genotypes and drug/immune-escape variants were characterized by comparing recently infected vs. more remotely infected blood donors.

Participants

This study included qualifying donations from 1 January 2006 through 31 December 31 2009 from 3 Retrovirus Epidemiology Donor Study-II (REDS-II) blood centers (Blood Centers of the Pacific, Blood Center of Wisconsin, and Hoxworth Blood Center/University of Cincinnati), all American Red Cross Blood Services regions, United Blood Services regions and the New York Blood Center. Together, these centers account for approximately 70% of the US blood supply.

Design

Infected donors were identified among approximately 34 million US blood donations, 2006–2009 based on screening and confirmatory tests for HIV and HCV nucleic acid testing, HIV and HCV antibody, HBsAg, and anti-HBV core antibody; incident infections were defined as having no or low antiviral antibody titers. Viral genomes were partially sequenced.

Conclusions

Viral genetic variant distribution in blood donors was similar to that seen in high-risk US populations. Blood-borne viruses detected through large-scale routine screening of blood donors can complement molecular surveillance studies of highly exposed populations. (Delwart et. al. 2012)

Additional Details

Study Population

Subjects:

12118

Age:

	Frequency	Percent
16-20	1442	11.90
21-25	897	7.40
26-30	877	7.24
31-35	815	6.73
36-40	1038	8.57
41-45	1429	11.79
46-50	2002	16.52
51-55	1856	15.32
56-60	1035	8.54
61-65	379	3.13
66-70	179	1.48
71-75	93	0.77
76-80	49	0.40
81-85	16	0.13
>=86	11	0.09

Sex:

	Frequency	Percent
NOT AVAILABLE	3	0.02
FEMALE	4366	36.03
MALE	7749	63.95

Race:

	Frequency	Percent
REFUSED	4	0.03
NOT AVAILABLE	2621	21.63
ASIAN	966	7.97
BLACK	1823	15.04
HISPANIC	918	7.58
NATIVE AMERICAN	91	0.75
WHITE	5352	44.17
MORE THAN ONE RACE	57	0.47
OTHER	286	2.36

Please note that researchers must be registered on this site to submit a request, and you will be prompted to log in. If you are not registered on this site, you can do so via the Request button. Registration is quick, easy and free.

Resources Available

Study Datasets Only

Study Catalog

Study Publications (17)

Study Documents

Persons using assistive technology may not be able to fully access information in the study documents. For assistance, Contact BioLINCC and include the web address and/or publication title in your message. If you need help accessing information in different file formats such as PDF, XLS, DOC, see Instructions for Downloading Viewers and Players.